Publication:
Effect of an intensive lifestyle intervention on the structural and functional substrate for atrial fibrillation in people with metabolic syndrome

dc.contributor.authorRosselló, Xavier
dc.contributor.authorRamallal, Raul
dc.contributor.authorRomaguera, Dora
dc.contributor.authorAlonso-Gómez, Ángel M
dc.contributor.authorAlonso, Alvaro
dc.contributor.authorTojal-Sierra, Lucas
dc.contributor.authorFernandez-Palomeque, Carlos
dc.contributor.authorMartínez-González, Miguel Ángel
dc.contributor.authorGarrido-Uriarte, María
dc.contributor.authorLópez, Luis
dc.contributor.authorDíaz, Agnes
dc.contributor.authorZaldua-Irastorza, Olatz
dc.contributor.authorShah, Amit J
dc.contributor.authorSalas-Salvado, Jordi
dc.contributor.authorFitó, Montserrat
dc.contributor.authorToledo, Estefanía
dc.date.accessioned2024-10-09T06:34:06Z
dc.date.available2024-10-09T06:34:06Z
dc.date.issued2023-12-15
dc.description.abstractAims: To evaluate the effect of an intensive lifestyle intervention (ILI) on the structural and functional cardiac substrate of atrial fibrillation (AF) in overweight or obese people with metabolic syndrome (Mets). Methods and results: Participants of the PREvención con DIeta MEDiterranea-Plus trial (n = 6874) were randomized 1:1 to an ILI programme based on an energy-reduced Mediterranean diet, increased physical activity, and cognitive-behavioural weight management or to a control intervention of low-intensity dietary advice. A core echocardiography lab evaluated left atrial (LA) strain, function, and volumes in 534 participants at baseline, 3-year, and 5-year follow-ups. Mixed models were used to evaluate the effect of the ILI on LA structure and function. In the subsample, the baseline mean age was 65 years [standard deviation (SD) 5 years], and 40% of the participants were women. The mean weight change after 5 years was -3.9 kg (SD 5.3 kg) in the ILI group and -0.3 kg (SD 5.1 kg) in the control group. Over the 5-year period, both groups experienced a worsening of LA structure and function, with increases in LA volumes and stiffness index and decreases in LA longitudinal strain, LA function index, and LA emptying fraction over time. Changes in the ILI and control groups were not significantly different for any of the primary outcomes {LA emptying fraction: -0.95% [95% confidence interval (CI) -0.93, -0.98] in the control group, -0.97% [95% CI -0.94, -1.00] in the ILI group, Pbetween groups = 0.80; LA longitudinal strain: 0.82% [95% CI 0.79, 0.85] in the control group, 0.85% [95% CI 0.82, 0.89] in the ILI group, Pbetween groups = 0.24} or any of the secondary outcomes. Conclusion: In overweight or obese people with Mets, an ILI had no impact on the underlying structural and functional LA substrate measurements associated with AF risk.en
dc.description.sponsorshipThe research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under award numbers R01HL137338 and K24HL148521. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was supported by the official Spanish Institutions for funding scientific biomedical research, Centro de Investigación Biomédica en Red (CIBER) Fisiopatología de la Obesidad y Nutrición (CIBEROBN), and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is cofunded by the European Regional Development Fund (six co-ordinated FIS projects, including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, and PI20/01158); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to J.S.-S.; the European Research Council (Advanced Research Grant 2014/19; agreement #340918) granted to M.�.M.-G.; the Recercaixa (La Caixa Foundation) (number 2013ACUP00194) grant to J.S.-S.; grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, and PI0137/2018); the PROMETEO/2017/017 grant from the Generalitat Valenciana; and the SEMERGEN grant. None of the funding sources were involved in the project design, in the collection, analysis, and interpretation of the data, in the writing of the report, or in the decision to submit the manuscript for publication.es_ES
dc.identifier.citationRossello X, Ramallal R, Romaguera D, Alonso-Gómez ÁM, Alonso A, Tojal-Sierra L, et al. Effect of an intensive lifestyle intervention on the structural and functional substrate for atrial fibrillation in people with metabolic syndrome. Eur J Prev Cardiol. 2023 Dec 15.en
dc.identifier.doi10.1093/eurjpc/zwad380
dc.identifier.e-issn2047-4881es_ES
dc.identifier.journalEuropean journal of preventive cardiologyes_ES
dc.identifier.otherhttps://hdl.handle.net/20.500.13003/20161
dc.identifier.pubmedID38102071es_ES
dc.identifier.puiL643036080
dc.identifier.urihttps://hdl.handle.net/20.500.12105/23648
dc.identifier.wos1133363300001
dc.language.isoengen
dc.publisherOxford University Press
dc.relation.publisherversionhttps://doi.org/10.1093/eurjpc/zwad380en
dc.rights.accessRightsopen accessen
dc.rights.licenseAttribution-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nd/4.0/*
dc.titleEffect of an intensive lifestyle intervention on the structural and functional substrate for atrial fibrillation in people with metabolic syndromeen
dc.typeresearch articleen
dspace.entity.typePublication
relation.isPublisherOfPublication465a0b1e-d9df-4342-b738-86ffcafc4bcf
relation.isPublisherOfPublication.latestForDiscovery465a0b1e-d9df-4342-b738-86ffcafc4bcf

Files